2011
Implantation Rate Remains Unaffected in Women with Endometriosis Compared to Tubal Factor Infertility
Matalliotakis I, Sakkas D, Illuzzi J, Matalliotaki C, Arici A. Implantation Rate Remains Unaffected in Women with Endometriosis Compared to Tubal Factor Infertility. Journal Of Endometriosis And Pelvic Pain Disorders 2011, 3: 86-92. DOI: 10.5301/je.2011.8528.Peer-Reviewed Original ResearchTubal factor infertilityMale infertilityTubal infertilityInfertility groupEndometriosis groupFactor infertilityImplantation rateAge-matched control groupMale infertility groupTubal infertility groupICSI treatment cyclesReduced pregnancy rateMethods Five hundredDelivery rateNumber of embryosConsecutive IVFIVF treatmentIVF programPregnancy rateUterine receptivityEndometriosisTreatment cyclesControl groupInfertilityPatients
2010
Effect of the new legislation and single-embryo transfer policy in Turkey on assisted reproduction outcomes: preliminary results
Kutlu P, Atvar O, Vanlioglu O, Kutlu U, Arici A, Yilmaz S, Yilmaz E, Delikara N, Bener F, Kamar A, Alpak O, Ozekici U. Effect of the new legislation and single-embryo transfer policy in Turkey on assisted reproduction outcomes: preliminary results. Reproductive BioMedicine Online 2010, 22: 208-214. PMID: 21195669, DOI: 10.1016/j.rbmo.2010.10.007.Peer-Reviewed Original ResearchConceptsMultiple pregnancy ratePregnancy rateAge groupsSingle embryo transfer policyOverall populationClinical pregnancy rateSecond treatment cycleAssisted reproduction outcomesYears of ageNumber of embryosDifferent age groupsClinical pregnancyMulticentre studyMultiple pregnanciesReproduction treatmentTreatment cyclesReproduction outcomesOlder agePregnancyOutcomesFurther investigationSignificant declineFurther cyclesAgeGroup
2008
Cycle outcome can be predicted by the growth profile of untransferred cleavage-stage embryos
Yilmaz S, Kutlu P, Sofuoglu K, Delikara N, Kolankaya A, Arici A. Cycle outcome can be predicted by the growth profile of untransferred cleavage-stage embryos. Reproductive BioMedicine Online 2008, 16: 124-128. PMID: 18252058, DOI: 10.1016/s1472-6483(10)60565-2.Peer-Reviewed Original ResearchConceptsGroup 1Pregnancy outcomesPregnancy rateGroup 2Intracytoplasmic sperm injection cyclesAssisted reproduction treatment cyclesBlastocyst formationSperm injection cyclesCycle outcomeIVF unitReceiving treatmentTreatment cyclesDay 5Excess embryosCleavage stage embryosPatientsOutcomesInjection cyclesDevelopmental potentialExtended culture
1999
Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin–timed versus urinary luteinizing hormone–timed intrauterine inseminations in clomiphene citrate–stimulated treatment cycles
Zreik T, Garcı́a-Velasco J, Habboosh M, Olive D, Arici A. Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin–timed versus urinary luteinizing hormone–timed intrauterine inseminations in clomiphene citrate–stimulated treatment cycles. Fertility And Sterility 1999, 71: 1070-1074. PMID: 10360912, DOI: 10.1016/s0015-0282(99)00116-8.Peer-Reviewed Original ResearchConceptsPregnancy rateClomiphene citrateCrossover studyUltrasound monitoringUrinary LH levelsReproductive Medicine CenterMale factor infertilityOverall pregnancy rateHCG timingLeading follicleUnexplained infertilityLH levelsUrinary LHFactor infertilityIntrauterine inseminationMenstrual cycleInfertile couplesMAIN OUTCOMEMedicine CenterProtocol BProtocol ADay 3IUITreatment cyclesDay 10